A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
Completed · Phase 1
Conditions studied: Schizophrenia
In brief
A clinical study to determine whether an investigational medication (SEP363856) changes how long it takes for food to move through the stomach into the small intestine in patients with schizophrenia. This study is accepting both male and female subjects. It will be conducted in approximately 6 study sites in the United States. The duration of participation will be approximtely 10 weeks.
Key facts
- Study ID
- NCT05402111
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- People needed
- 31
- Starts
- 2022-06-13
- Expected to finish
- 2023-09-27
- Last updated by the study team
- 2024-06-26
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Woodland International Research Group — Little Rock, Arkansas, United States
- Woodland Research Northwest, LLC — Rogers, Arkansas, United States
- Collaborative Neuroscience Research, LLC — Long Beach, California, United States
- CNRI - San Diego, LLC — San Diego, California, United States
- Galiz Research — Hialeah, Florida, United States
- Research Centers of America — Oakland Park, Florida, United States
- Pillar Clinical Research LLC — Richardson, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.